Call Us Today at 508-231-8842        EMERGENCY

November 14, 2019, Ashland, MA – MEDIcept Inc., a leading international Quality and Regulatory consulting firm focused on medical device and invitro diagnostics, and ACMP Consulting, Acton, MA have entered into an agreement to provide Clinical Research Organization (CRO) services for early phase, pre-, and post-market studies to the healthcare industry.

The MEDIcept/ACMP agreement will offer medical device companies full clinical operations support, including:

  • protocol development,
  • site start-up activities,
  • IRB communication,
  • trial monitoring,
  • biostatistics,
  • data management,
  • data and safety monitoring and Committees (CEC and DSMB),
  • medical writing, and
  • other consulting services such vendor management and clinical audits.

MEDIcept President, David Rothkopf, said: “MEDIcept plays an important role in the medical device and biotech industry as a champion of quality and regulatory practices. The new relationship expands and strengthens our services to our customer base to develop products and services that will protect and improve human health while minimizing inefficiencies to save time and reduce unnecessary costs. With the addition of CRO service we can better develop efficient and effective strategies for the submission and approval of devices.”

Dr. Adelina Paunescu, Principal of ACMP said: “The complementary synergies between our companies will increase service offerings. ACMP will be able to leverage MEDIcept’ s global relationships to expand our contract research capabilities and better serve our clients with design and execution of clinical trials. With this collaboration, MEDIcept and ACMP can serve our clients with full scope, from development, clinical trial data and regulatory authorities’ submissions to a successful clearance and approval.”

Sign up to receive our Newsletters!

The Latest News

Quality Systems in Motion, Inc. (QSIM) is now part of MEDIcept Inc.

For Immediate Release Ashland, MA: MEDIcept Inc, an international quality, regulatory, and clinical consulting firm focused on medical device and in-vitro diagnostics (IVD), and QSIM, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies. QSIM, under the direction of Brian Markham, President, specialized in providing leadership and resources for organizations undergoing significant quality system change due to...

Medical Device Risk Management: An ISO14971 Update

In 2000, the first edition of ISO 14971 was released as the international standard for risk management of medical devices. This year, the ISO technical committee (ISO/TC 210) has been hard at work updating this globally-recognized standard. And while the fundamental stages of the risk management process remain unchanged, there are some key modifications that medical device manufacturers should be aware of to ensure that they can successfully navigate the development, testing, and launching of...

Europe’s New Medical Devices Regulation: Ready or Not, Here It Comes

For the past 30 years, the European Union’s medical device market has been regulated by the Medical Devices Directive (MDD). The rapid development of hybrid technologies, tensions between EU member states, and highly bureaucratic procedures for resolving disputes made the text of the Medical Devices Directives seem obsolete much earlier than anticipated. As a result, the European Commission authorized the development of a new set of industry requirements known as the Medical Devices Regulation...